Incyte board member Susanne Schaffert to step down in April

2026-04-05 22:16:24

Abstract generation in progress

Susanne Schaffert has announced her resignation from Incyte’s board of directors, effective April 15, 2026, a decision not related to disagreements with the company. Incyte has shown strong financial performance, despite mixed analyst reactions to recent drug trial results and some adjusted price targets. The company also recently appointed Pablo J. Cagnoni as President and Global Head of Research and Development.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes